Hetero-Diels–Alder Addition of Ethyl 2-Nitrosoacrylate to (Z)-Prop-1-enyl Ethers. Stereoselective Synthesis of a Precursor to Sacubitril

Stavroula A. Zisopoulou; Thanos Andreou; Theocharis V. Koftis; John K. Gallos; Christos I. Stathakis

doi:10.1055/a-2029-0015

Synthesis, Table of Contents

Synthesis 2023; 55(10): 1507-1516
DOI: 10.1055/a-2029-0015

feature

Hetero-Diels–Alder Addition of Ethyl 2-Nitrosoacrylate to (Z)-Prop-1-enyl Ethers. Stereoselective Synthesis of a Precursor to Sacubitril

Authors

Stavroula A. Zisopoulou

^aDepartment of Chemistry, Aristotle University of Thessaloniki, Thessaloniki 54124, Greece
Thanos Andreou

^bPharmathen Industrial S.A., 9^th km Thermi-Thessaloniki, Thessaloniki 57001, Greece
Theocharis V. Koftis

^bPharmathen Industrial S.A., 9^th km Thermi-Thessaloniki, Thessaloniki 57001, Greece
John K. Gallos∗

^aDepartment of Chemistry, Aristotle University of Thessaloniki, Thessaloniki 54124, Greece
Christos I. Stathakis∗

^aDepartment of Chemistry, Aristotle University of Thessaloniki, Thessaloniki 54124, Greece

Abstract

All articles of this category

Abstract

A novel, conceptually distinct synthesis of a key precursor to sacubitril, an antihypertensive drug, is presented. The well-demonstrated hetero-Diels–Alder addition of in situ generated nitrosoalkenes to electron-rich enol ethers was engaged to establish the required functionalities with controllable relative stereochemistry. An asymmetric variant of the enol ether enabled access to the target molecule in enantiopure form.

Key words

sacubitril - hetero-Diels–Alder reaction - nitrosoalkenes - oxazinanes - chiral auxiliary

Full Text

References

References

1a McCormack PL. Drugs 2016; 76: 387
1b Andersen MB, Simonsen U, Wehland M, Pietsch J, Grimm DL. Basic Clin. Pharmacol. Toxicol. 2016; 118: 14

2 Vilela-Martin JF. Drug Des., Dev. Ther. 2016; 10: 1627

3a McMurray JJ. Eur. J. Heart Failure 2015; 17: 242
3b Schiering N, D’Arcy A, Villard F, Ramage P, Logel C, Cumin F, Ksander GM, Wiesmann C, Karki RG, Mogi M. Sci. Rep. 2016; 6: 27909

4 Ksander GM, Ghai RD, deJesus R, Diefenbacher CG, Yuan A, Berry C, Sakane Y, Trapani A. J. Med. Chem. 1995; 38: 1689

5a Flick AC, Ding HX, Leverett CA, Kyne RE. Jr, Liu KK.-C, Fink SJ, O’Donnell CJ. J. Med. Chem. 2017; 60: 6480
5b Wang Y, Chen F.-E, Shi Y, Tian W.-S. Tetrahedron Lett. 2016; 57: 5928
5c Halama A, Zapadlo M. Org. Process Res. Dev. 2019; 23: 102
5d Teyssier VR, Simard J.-M, Dornan MH, Tournoux F, DaSilva JN. J. Labelled Compd. Radiopharm. 2020; 63: 65

Selected patents:

6a Hook D, Ruch T, Riss B, Wietfeld B, Sedelmeier G, Napp M, Banziger M, Hawker S, Ciszewski L, Waykole LM. WO2008083967A2, 2008
6b Hook D, Zhou J, Li Y, Ku J. WO2011088797A1, 2011
6c Hook D, Zhou J, Li Y. WO2012025501A1, 2012
6d Hook D, Riss B, Zhou J, Li Y, Bappert E. WO2012025502A1, 2012
6e Zhu G, Ye W, Zheng H, Qian L, Wei J, Yang L, Li Y, Luo L. WO2014032627A1, 2014
6f Hook D, Wietfeld B, Lotz M. WO2008031567A1, 2008
6g Ksander G. US5217996A, 1993
6h Halama A, Zvatora P, Dammer O, Stach J, Zapadlo M, Krejcik L, Voslar M. WO2016074651A1, 2016
6i Feng L, Godtfredsen SE, Karpinski P, Sutton PA, Prashad M, Girgis MJ, Hu B, Liu Y, Blacklock TJ. WO2007056546A1, 2007
6j Martin B, Kleinbeck-Rinik FK, Penn G, Venturoni F, Sedelmeier J, Sedelmeier G, Mafli I. WO2018033866A1, 2018
6k Hook D, Riss B, Kaufmann D, Napp M, Bappert E, Polleux P, Medlock J, Zanotti-Gerosa A. WO2009090251A2, 2009
6l Halama A, Zvatora P, Voslar M, Stach J, Zapaldo M, Dammer O, Krejcik L, Dvorakova L, Rezankova M, Vyslouzil R. WO2017097275A1, 2017
6m Zhang B. CN105566194, 2016
6n Yu W, Jiang H. CN106496055, 2017
6o Huang W, Shan X, Chen X, Hu E, Zhang J. CN106810485, 2017
6p Li T, Wang B. CN109384701, 2019

7a Lau S.-H, Bourne SL, Martin B, Schenkel B, Penn G, Ley SV. Org. Lett. 2015; 17: 5436
7b Hiebler K, Dertnig C, Soritz S, Maier MC, Hörmann TR, Grabner B, Gruber-Woelfler H. J. Flow Chem. 2020; 10: 259
7c Hiebler K, Lichtenegger GJ, Maier MC, Park ES, Gonzales-Groom R, Binks BP, Gruber-Woelfler H. Beilstein J. Org. Chem. 2018; 14: 648

8a Reissig H.-U, Zimmer R. In Science of Synthesis, Vol. 33. Molander GA. Thieme; Stuttgart: 2007: 371
8b Gilchrist TL. Chem. Soc. Rev. 1983; 12: 53

9 Lopes SM. M, Cardoso AL, Lemos A, Pinho e Melo TM. V. D. Chem. Rev. 2018; 118: 11324 ; and references cited therein

10a Gallos JK, Sarli VC, Varvogli AC, Papadoyanni CZ, Papaspyrou SD, Argyropoulos NG. Tetrahedron Lett. 2003; 44: 3905
10b Gallos JK, Sarli VC, Massen ZS, Varvogli AC, Papadoyanni CZ, Papaspyrou SD, Argyropoulos NG. Tetrahedron 2005; 61: 565
10c Massen ZS, Sarli VC, Coutouli-Argyropoulou E, Gallos JK. Carbohydr. Res. 2011; 346: 230
10d Massen ZS, Gallos JK. J. Heterocycl. Chem. 2012; 49: 1214

11a Gallos JK, Sarli VC, Koftis TV, Coutouli-Argyropoulou E. Tetrahedron Lett. 2000; 41: 4819
11b Gallos JK, Sarli VC, Stathakis CI, Koftis TV, Nachmia VR, Coutouli-Argyropoulou E. Tetrahedron 2002; 58: 9351
11c Massen ZS, Coutouli-Argyropoulou E, Sarli VC, Gallos JK. Carbohydr. Res. 2011; 346: 508
11d Serafidou A.-T, Yioti EG, Gallos JK. Eur. J. Org. Chem. 2013; 939

12 Yioti EG, Mati IK, Arvanitidis AG, Massen ZS, Alexandraki ES, Gallos JK. Synthesis 2011; 142
13 Ahmad SA. Z, Jena TK. Chem. Asian J. 2021; 16: 1685
14 Prosser TJ. J. Am. Chem. Soc. 1961; 83: 1701

15a Zimmer R, Arnold T, Homann K, Reissig H.-U. Synthesis 1994; 1050
15b Tsipis CA, Bakalbassis EB, Zisopoulou SA, Gallos JK. Org. Biomol. Chem. 2021; 19: 1066

16 Armstrong RW, DeMattei JA. Tetrahedron Lett. 1991; 32: 5749
17 Arnold T, Orschel B, Reissig H.-U. Angew. Chem., Int. Ed. Engl. 1992; 31: 1033
18 Arnold T, Reissig H.-U. Synlett 1990; 514
19 Murphy AC, Mitova MI, Blunt JW, Munro MH. G. J. Nat. Prod. 2008; 71: 806
20 Motoyama Y, Abe M, Kamo K, Kosakoa Y, Nagashima H. Chem. Commun. 2008; 5321
21 Huang G, Ke M, Tao Y, Chen F. J. Org. Chem. 2020; 85: 5321
22 Compounds 38a,b and 43–45 appear as mixtures of conformers, presumably due to restricted rotation of one of the etheric bonds connecting the chiral auxiliary with the oxazine heterocycle; therefore, their NMR spectra look complex. This was verified by recording ¹H NMR spectra at higher temperature, where some of the peaks collapsed to one. In addition, by removing the auxiliary at the reductive ring contraction stage, only a sole product was obtained.

Supplementary Material

Supporting Information (PDF)